A variety of cytokines play a role in the inflammatory response. Interleukin-6 (IL-6)-type cytokines are released in response to tissue injury or an inflammatory stimulus, and act locally and systemically to generate a variety of physiologic responses. Interleukin-6 concentrations are elevated after surgery, trauma, and critical illness. The magnitude of IL-6 elevation correlates with the extent of tissue trauma/injury severity. Furthermore, there is an association between IL-6 elevation and adverse outcome. Interleukin-6 levels can also be used to stratify patients for therapeutic intervention.
Kabir K., Keller H., Grass G., et al. Cytokines and chemokines in serum and urine as early predictors to identify septic patients on intensive care unit. Int J Mol Med. 2003;12(4):565-570.
2.
May L., Ndubisi M., Patel K., Garcia D.Interleukin-6 chaperones in blood. Ann N Y Acad Sci . 1995;762(1):120-128.
3.
Corbi P., Rahmati M., Delwail A., et al. Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation. Eur J Cardiothorac Surg. 2000;18(1):98-103.
4.
Ndubuisi MI, Patel K., Rayanade RJ, Mittelman A., May LT, Sehgal PBDistinct classes of chaperoned IL-6 in human blood: differential immunological and biological availability. J Immunol. 1998 ;160(1):494-501.
5.
Schietroma M. , Carlei F., Franchi L., et al. A comparison of serum interleukin-6 concentrations in patients treated by cholecystectomy via laparotomy or laparoscopy . Hepatogastroenterology. 2004;51(60):1595-1599.
6.
Pignatti P., Ciapponi L., Galle P., et al. High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130. Clin Exp Immunol. 2003;131(2): 355-363.
7.
Watanabe E., Hirasawa H., Oda S., Matsuda K., Hatano M., Tokuhisa T.Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor-and interleukin-1-related gene polymorphisms . Crit Care Med. 2005;33(1):89-97.
8.
Derhaschnig U., Bergmair D., Marsik C., Schlifke I., Wijdenes J., Jilma B.Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Crit Care Med. 2004; 32(5):1136-1140. Erratum in: Crit Care Med. 2004;32:1813.
9.
Bataille R., Klein B.C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum. 1992; 35(8):982-984.
10.
Gebhard F., Pfetsch H., Steinbach G., Strecker W., Kinzl L., Bruckner UBIs interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg. 2000;135(3): 291-295.
11.
Hildebrandt U. , Kessler K., Plusczyk T., Pistorius G., Vollmar B., Menger MDComparison of surgical stress between laparoscopic and open colonic resections. Surg Endosc. 2003;17(2):242-246.
12.
Sari R., Sevinc A.The effects of laparascopic cholecystectomy operation on C-reactive protein, hormones, and cytokines. J Endocrinol Invest. 2004;27(2):106-110.
13.
Black S., Kushner I., Samols D.C-reactive Protein. J Biol Chem.2004 ;279(47):48487-48490.
14.
Kushner I., Rzewnicki DLThe acute phase response: general aspects. Baillieres Clin Rheumatol. 1994;8(3):513-530.
15.
Grande M., Tucci GF, Adorisio O., et al. Systemic acute-phase response after laparoscopic and open cholecystectomy . Surg Endosc. 2002;16(2):313-316.
16.
Dunker MS, Ten Hove T., Bemelman WA, Slors JF, Gouma DJ, Van Deventer SJInterleukin-6, C-reactive protein, and expression of human leukocyte antigen-DR on peripheral blood mononuclear cells in patients after laparoscopic vs. conventional bowel resection: a randomized study. Dis Colon Rectum. 2003; 46(9):1238-1244.
17.
Ordemann J. , Jacobi CA, Schwenk W., Stosslein R., Muller JMCellular and humoral inflammatory response after laparoscopic and conventional colorectal resections. Surg Endosc. 2001; 15(6):600-608.
18.
Leung KL, Lai PB, Ho RL, et al. Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: a prospective randomized trial. Ann Surg. 2000;231(4):506-511.
19.
Yahara N., Abe T., Morita K., Tangoku A., Oka M.Comparison of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor production by the peritoneum in laparoscopic and open surgery. Surg Endosc. 2002;16(11):1615-1619.
20.
Ohzato H., Yoshizaki K., Nishimoto N., et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery. 1992;111(2):201-209.
21.
Kashiwabara M., Miyashita M., Nomura T., et al. Surgical trauma-induced adrenal insufficiency is associated with postoperative inflammatory responses . J Nippon Med Sch. 2007;74(4):274-283.
22.
Delgado S., Lacy AM, Filella X., et al. Acute phase response in laparoscopic and open colectomy in colon cancer: randomized study. Dis Colon Rectum. 2001;44(5):638-646.
23.
Kristiansson M., Saraste L., Soop M., Sundqvist KG, Thörne A.Diminished interleukin-6 and C-reactive protein responses to laparoscopic versus open cholecystectomy. Acta Anaesthesiol Scand. 1999;43(2):146-152.
24.
Haq Z., Rahman M., Siddique MA, Roy RK, Rahman AM, Khatun M.Interleukin-6 (IL-6) and tumour necrosis factor-alpha in open and laparoscopic cholecystectomy. Mymensingh Med J. 2004;13(2):153-156.
25.
Schwenk W., Jacobi C., Mansmann U., Bohm B., Muller JMInflammatory response after laparoscopic and conventional colorectal resections - results of a prospective randomized trial. Langenbecks Arch Surg. 2000;385(1):2-9.
26.
Nishiguchi K., Okuda J., Toyoda M., Tanaka K., Tanigawa N.Comparative evaluation of surgical stress of laparoscopic and open surgeries for colorectal carcinoma. Dis Colon Rectum. 2001;44(2):223-230.
27.
Zvonic S., Baugh JEJrArbourReily P., Mynatt RL, Stephens JMCross-talk among gp130 cytokines in adipocytes. J Biol Chem . 2005;280(40):33856-33863.
28.
Haveman JW, van den Berg AP, Verhoeven EL, et al. HLA-DR expression on monocytes and systemic inflammation in patients with ruptured abdominal aortic aneurysms. Crit Care . 2006; 10(4):R119.
29.
Bown MJ, Horsburgh T., Nicholson ML, Bell PR, Sayers RDCytokines, their genetic polymorphisms, and outcome after abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2004;28(3):274-280.
30.
Maier B., Lefering R., Lehnert M., et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock. 2007;28(6):668-674.
31.
Stensballe J., Christiansen M., Tønnesen E., Espersen K., Lippert FK, Rasmussen LSThe early IL-6 and IL-10 response in trauma is correlated with injury severity and mortality . Acta Anaesthesiol Scand.2009;53(4):515-521.
32.
Spindler-Vesel A., Wraber B., Vovk I., Kompan L.Intestinal permeability and cytokine inflammatory response in multiply injured patients. J Interferon Cytokine Res. 2006;26(10):771-776.
33.
Schinkel C. , Wick M., Muhr G., Köller M.Analysis of systemic interleukin-11 after major trauma. Shock. 2005;23(1):30-34.
34.
Heizmann O. , Koeller M., Muhr G., Oertli D., Schinkel C.Th1- and Th2-type cytokines in plasma after major trauma. J Trauma. 2008;65(6):1374-1378.
35.
Mimasaka S. , Hashiyada M., Nata M., Funayama M.Correlation between serum IL-6 levels and death: usefulness in diagnosis of ‘‘traumatic shock’’?Tohoku J Exp Med. 2001 ;193(4):319-324.
36.
Mimasaka S.Postmortem cytokine levels and the cause of death. Tohoku J Exp Med. 2002;197(7):145-150.
37.
Mimasaka S. , Ohtsu Y., Tsunenari S., Funayama M.Postmortem cytokine levels and severity of traumatic injuries. Int J Legal Med. 2006;120(5):265-270.
38.
Pathan N., Hemingway CA, Alizadeh AA, et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet. 2004;363(9404):203-209.
39.
Pathan N., Williams EJ, Oragui EE, Stephens AC, Levin M.Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shock. Crit Care Med. 2005;33(8): 1839-1844.
40.
Sikora JP, Chlebna-Sokół D. , Krzyzańska-Oberbek A.Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants . Arch Immunol Ther Exp (Warsz.). 2001;49(5):399-404.
41.
Stryjewski GR, Nylen ES, Bell MJ, et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med. 2005;6(2): 129-135.
42.
Harbarth S. , Holeckova K., Froidevaux C., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164(3):396-402.
43.
Selberg O., Hecker H., Martin M., Klos A., Bautsch W., Kohl J.Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med. 2000 ;28(8):2793-2798.
44.
Schlüter B., Raufhake C., Erren M., et al. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med. 2002;30(1):32-37.
45.
Sutherland AM , Walley KR, Manocha S., Russell JAThe association of interleukin 6 haplotype clades with mortality in critically ill adults . Arch Intern Med. 2005;165(1):75-82.
46.
Watanabe E. , Hirasawa H., Oda S., et al. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications . J Trauma. 2005;59(5):1181-1189.
47.
Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699-709.
48.
Kinasewitz GT, Yan SB, Basson B., et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care . 2004 ;8(2):R82-R90.
49.
Abraham E., Laterre PF, Garbino J., et al. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med. 2001;29(3):503-510.
50.
Panacek EA, Marshall JC, Albertson TE, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab’)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004;32(11):2173-2182.
51.
Reinhart K. , Menges T., Gardlund B., et al. Randomized, placebo controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med. 2001; 29(4):765-769.
52.
Stiletto RJ , Baacke M., Gotzen L., Lefering R., Renz H.Procalcitonin versus interleukin-6 levels in bronchoalveolar lavage fluids of trauma victims with severe lung contusion . Crit Care Med. 2001 ; 29(9):1690-1693.
53.
Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33:1-6.
54.
Ranieri VM, Suter PM, Tortorella C., et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282(1):54-61.
55.
Geppert A., Steiner A., Zorn G., et al. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med. 2002;30(9): 1987-1994.
56.
Geppert A., Dorninger A., Delle-Karth G., Zorn G., Heinz G., Huber K.Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction . Crit Care Med. 2006; 34(8):2035-2042.
57.
Funayama H. , Ishikawa S., Kubo N., et al. Increases in interleukin-6 and metalloproteinase-9 in the infarct related coronary artery of acute myocardial infarction. Circ J. 2004;68(5):451-454.
58.
Acalovschi D., Wiest T., Hartmann M., et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke . 2003 ; 34(8):1864-1869.
59.
Dziedzic T. , Bartus S., Klimkowicz A., Motyl M., Slowik A., Szczudlik A.Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke. 2002;33(9):2334-2335.
60.
Beeton CA, Chatfield D., Brooks RA, Rushton N.Circulating levels of interleukin-6 and its soluble receptor in patients with head injury and fracture. J Bone Joint Surg Br. 2004;86(6):912-917.
61.
Osuchowski MF, Welch K., Siddiqui J., Remick DGCirculating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality . J Immunol. 2006;177(3):1967-1974.
62.
Andrejko KM , Raj NR, Kim PK, Cereda M., Deutschman CSIL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters. Shock. 2008;29(4): 490-496.
63.
Tanimoto K. , Saito Y., Hamanaka I., et al. SOCS1/JAB likely mediates the protective effect of cardiotrophin-1 against lipopolysaccharide-induced left ventricular dysfunction in vivo. Circ J. 2005;69(11):1412-1417.
64.
Pan W., Yu C., Hsuchou H., Zhang Y., Kastin AJNeuroinflammation facilitates LIF entry into brain: role of TNF. Am J Physiol Cell Physiol. 2008;294(6):C1436-C1442.
65.
Wahl AF, Wallace PM. Oncostatin M in the anti-inflammatory response. Rev Physiol Biochem Pharmacol. 2003;149(5):39-52.
66.
von Dossow V., Rotard K., Redlich U., Hein OV, Spies CDCirculating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients . Crit Care. 2005;9(6):R662-R669.
67.
Jawa R., Kulayalat M., Baumann H., Dayton M.What is new in cytokine research related to Trauma/Critical Care. J Intensive Care Med. 2006;21(2):63-85.
68.
Puneet P., Moochhala S., Bhatia M.Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2005;288(1):L3-L15.
69.
Wrigge H., Zinserling J., Stuber F., et al. Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function. Anesthesiology. 2007; 93(6):1413-1417.
70.
Halbertsma FJ, Vaneker M., Scheffer GJ, van der Hoeven JGCytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med. 2005;63(10): 382-392.
71.
Chu EK, Whitehead T., Slutsky ASEffects of cyclic opening and closing at low- and high-volume ventilation on bronchoalveolar lavage cytokines. Crit Care Med. 2004;32(1):168-174.
72.
Crestani B. , Cornillet P., Dehoux M., Rolland C., Guenounou M., Aubier M.Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J Clin Invest. 1994;94(2):731-740.
73.
Zachlederova’ M., Jarolím P.The dynamics of gene expression in human lung microvascular endothelial cells after stimulation with inflammatory cytokines. Physiol Res. 2006;55(1): 39-47.
74.
Cuzzocrea S. , Sautebin L., De Sarro G., et al. Role of IL-6 in the pleurisy and lung injury caused by carrageenan . J Immunol. 1999;163(9):5094-5104.
75.
Meduri GU, Kanangat S., Stefan J., Tolley E., Schaberg D.Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vivo growth of bacteria . Am J Respir Crit Care Med. 1999 ;160(3): 961-967.
76.
Schütte H., Lohmeyer J., Rosseau S., et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J. 1996; 9(9):1858-1867.
77.
Yu X., Kennedy RH, Liu SJJAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes . J Biol Chem. 2002;278:16304-16309.
78.
Hamanaka I. , Saito Y., Nishikimi T., et al. Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart. Am J Physiol Heart Circ Physiol. 2000;279(1):H388-H396.
79.
Nathan N., Denizot Y., Cornu E., Jauberteau MO, Chauvreau C., Feiss P.Cytokine and lipid mediator blood concentrations after coronary artery surgery . Anesth Analg. 1997;85(6):1240-1246.
80.
Funayama H. , Ishikawa SE, Kubo N., Yasu T., Saito M., Kawakami M.Close association of regional interleukin-6 levels in the infarct-related culprit coronary artery with restenosis in acute myocardial infarction. Circ J. 2006;70(4):426-429.
81.
Schlosser HG , Volk HD, Splettstösser G., Brock M., Woiciechowsky C.A new qualitative interleukin-6 bedside test can predict pneumonia in patients with severe head injury-comparison to the standard Immulite test and a semiquantitative bedside test. J Neurosurg Anesthesiol. 2007;19(1):5-9.
82.
Shalhub S., Junker CE, Imahara SD, Mindrinos MN, Dissanaike S., O’Keefe GEVariation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study. J Trauma. 2009 ;66(1):115-122.
